NFKB1 and COVID-19: On the other hand, inhibition of the nuclear factor kappa-light-chain-enhancer of activated B (NF-κB) pathway in COVID-19 mice led to a reduction of inflammation and lung pathology in infected animals [101,102], showing the importance of NF-κB pathway regulation for a controlled immune response [103].